Is BPC-157 legal in the US?

It is not an approved medicine, and the FDA has placed it in the category of bulk substances raising significant safety concerns for compounding. Material sold online is generally offered for laboratory research use rather than human use.

Can they be used together?

Stacking is widely discussed online. Neither compound is approved, there is no established human protocol for either alone, and combining two unapproved substances compounds the unknowns rather than resolving them.

Is TB-500 the same as thymosin beta-4?

They are related but not identical. TB-500 is a synthetic peptide associated with a fragment of that protein, and the two names are often used interchangeably when they should not be.

Are they detectable in drug testing?

Both are on the WADA prohibited list, and testing methods exist for this class. Assume detectable.

BPC-157 vs TB-500

These two are discussed together so routinely that people assume they are variants of one thing. They are not. BPC-157 derives from a sequence found in gastric juice; TB-500 relates to thymosin beta-4, a protein involved in cell structure and movement.

What they genuinely share is regulatory status, and it is the most important thing on this page: neither is an approved medicine in the United States.

BPC-157Gastric peptide fragment
TB-500Thymosin beta-4 related
US statusNot FDA-approved
SportWADA-prohibited

Where each comes from

BPC-157 is a synthetic peptide corresponding to a fragment of a protein identified in gastric juice. The initials stand for body protection compound, a name given by the researchers who first characterised it.

TB-500 is a synthetic peptide related to thymosin beta-4, a naturally occurring protein involved in actin regulation — essentially the scaffolding cells use to hold shape and move. The two are frequently conflated, but TB-500 and thymosin beta-4 itself are not identical.

Most of what circulates about both comes from preclinical work — laboratory and animal studies. What research explores in that setting does not transfer automatically to humans, and the absence of substantial human trial data is the central fact about both compounds.

Regulatory status in the US

Neither is an FDA-approved medicine. Both circulate as research chemicals sold for laboratory use, and material sold that way is not made to pharmaceutical standards, is not tested for identity or purity in the way a prescription drug is, and offers no assurance that the vial contains what the label says.

The FDA has additionally placed BPC-157 in the category of bulk substances that raise significant safety concerns for use in compounding, which restricts lawful preparation by compounding pharmacies. TB-500 likewise has no approved status.

Both fall under the World Anti-Doping Agency's prohibited list. For anyone competing under a testing body, that ends the discussion.

Side by side

/ BPC-157 / TB-500
	BPC-157	TB-500
Origin	Fragment of a gastric protein	Related to thymosin beta-4
Studied in	Largely preclinical models	Largely preclinical models
US approval	None	None
Compounding	FDA category raising significant safety concerns	No approved status
Sport	Prohibited	Prohibited

If you are considering either

Talk to a licensed clinician about what you are actually trying to address. In most cases the underlying issue has established options with real evidence behind them, and those are worth exhausting before anything experimental enters the conversation.

Dosing is determined by a licensed provider. Protocols circulating online are not medical advice and were not written with your history in mind.

How we verify providers

Questions

BPC-157 vs TB-500: common questions

Is BPC-157 legal in the US?: It is not an approved medicine, and the FDA has placed it in the category of bulk substances raising significant safety concerns for compounding. Material sold online is generally offered for laboratory research use rather than human use.
Can they be used together?: Stacking is widely discussed online. Neither compound is approved, there is no established human protocol for either alone, and combining two unapproved substances compounds the unknowns rather than resolving them.
Is TB-500 the same as thymosin beta-4?: They are related but not identical. TB-500 is a synthetic peptide associated with a fragment of that protein, and the two names are often used interchangeably when they should not be.
Are they detectable in drug testing?: Both are on the WADA prohibited list, and testing methods exist for this class. Assume detectable.

Talk to a licensed provider first

Neither of these is an approved medicine, and what you are trying to address may well have an established option with real evidence behind it. We connect you with licensed providers who can look properly.

Find a licensed provider

TreatRadar is an information and referral service. We are not a medical provider, we do not practise medicine, and nothing here is medical advice, diagnosis, or a treatment recommendation. Decisions about treatment belong to you and a licensed clinician who knows your history.

We may be compensated when you connect with a provider through this site. That never changes which providers we list or how we describe them — how we verify providers.

Some information (pricing, provider coverage, state rules) may change or await verification — confirm details directly with the provider or the relevant state medical board before booking.